Private equity firm Segulah has announced it is looking to sell its complete stake in Medstop Group Holding AB, whose pharmacy chain holds a 7.5 percent share of the Swedish pharmacy market, to Oriola-KD Holdings Sverige AB. The deal will result in Oriola’s possession of about 300 pharmacies around the nation, increasing its stake in the market from 14 percent to about 21 percent. Segulah originally acquired its 100 percent stake in the Medstop pharmacy chain as part of the privatization of Apoteket AB, a former pharmacy monopoly, in February 2010.
Featured News
Proposal Calls for Treating Digital Platform Design Standards Like Physical Infrastructure
Mar 16, 2026 by
CPI
Europe’s Cybersecurity Clock Is Ticking. Here’s What Companies Need to Know
Mar 16, 2026 by
CPI
European Publishers and Startups Call for Swift EU Decision in Google Case
Mar 16, 2026 by
CPI
Jane Fonda Wears ‘Block the Merger’ Pin to Protest Paramount–Warner Bros. Deal
Mar 16, 2026 by
CPI
Encyclopaedia Britannica Sues OpenAI Over Alleged Use of Content to Train AI Models
Mar 16, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece